Last Updated:
Name Designation Appointment Date Status
Shivapura Bhadraiah Gangadhar

Appointed as Director since July 2021

Director 20-Jul-2021 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Latha Gangadhar

Appointed as Director since November 2024

Director 01-Nov-2024 Current
Thushar Shivapura Gangadhar

Appointed as Managing Director since July 2021

Managing Director 20-Jul-2021 Current

People Timeline

Explore the timeline of key personnel in Acurela Pharms Limited's leadership journey.

Loading...
Contact Details
  • Address #1335, 3Rd Cross, M R H B Colony Vijaynagar, Bangalore Karnataka, 560079, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 560079
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Acurela Pharms Limited?
You can contact Acurela Pharms Limited through their registered address at #1335, 3Rd Cross, M R H B Colony Vijaynagar, Bangalore Karnataka, 560079, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Acurela Pharms Limited?
The current directors of Acurela Pharms Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SHIVAPURA BHADRAIAH GANGADHAR
  • LATHA GANGADHAR
  • THUSHAR SHIVAPURA GANGADHAR
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available